{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:08:00Z","timestamp":1792804080362,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00198-023-06690-1","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T01:03:01Z","timestamp":1675299781000},"page":"735-740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9858-5398","authenticated-orcid":false,"given":"Carrie","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kolinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"6690_CR1","doi-asserted-by":"publisher","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","volume":"2","author":"A Haslam","year":"2019","unstructured":"Haslam A, Prasad V (2019) Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw Open 2:e192535","journal-title":"JAMA Netw Open"},{"key":"6690_CR2","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.2147\/OTT.S150817","volume":"11","author":"E Grywalska","year":"2018","unstructured":"Grywalska E, Pasiarski M, G\u00f3\u017ad\u017a S, Roli\u0144ski J (2018) Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer. Onco Targets Ther 11:6505\u20136524","journal-title":"Onco Targets Ther"},{"key":"6690_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD (2018) Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378:158\u2013168","journal-title":"N Engl J Med"},{"key":"6690_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1359\/jbmr.2001.16.2.328","volume":"16","author":"MN Weitzmann","year":"2001","unstructured":"Weitzmann MN, Cenci S, Rifas L et al (2001) T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res 16:328\u2013337","journal-title":"J Bone Miner Res"},{"key":"6690_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"Black DM, Rosen CJ (2016) Clinical practice. Postmenopausal osteoporosis. N Engl J Med 374:254\u2013262","journal-title":"N Engl J Med"},{"key":"6690_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/ijc.33592","volume":"149","author":"DM Filippini","year":"2021","unstructured":"Filippini DM, Gatti M, Di Martino V et al (2021) Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: case series and large-scale pharmacovigilance analysis. Int J Cancer 149:675\u2013683","journal-title":"Int J Cancer"},{"issue":"1","key":"6690_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40425-018-0417-8","volume":"6","author":"KF Moseley","year":"2018","unstructured":"Moseley KF, Naidoo J, Bingham CO, Carducci MA, Forde PM, Gibney GT, Lipson EJ, Shah AA, Sharfman WH, Cappelli LC (2018) Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series. J Immunother Cancer. 6(1):104","journal-title":"J Immunother Cancer."},{"key":"6690_CR8","unstructured":"Statistics Canada\u00a0(2019) Table 17-10-0005--01. Population estimates on July 1st, by age and sex"},{"key":"6690_CR9","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.3747\/co.27.5861","volume":"27","author":"ZF Cairncross","year":"2020","unstructured":"Cairncross ZF, Nelson G, Shack L, Metcalfe A (2020) Validation in Alberta of an administrative data algorithm to identify cancer recurrence. Curr Oncol 27:e343\u2013e346","journal-title":"Curr Oncol"},{"key":"6690_CR10","volume-title":"The 2019 report on cancer statistics in Alberta","author":"C Alberta","year":"2019","unstructured":"Alberta C (2019) The 2019 report on cancer statistics in Alberta. Alberta Health Services, Edmonton"},{"key":"6690_CR11","doi-asserted-by":"crossref","unstructured":"O'Donnell S (2013) Canadian chronic disease surveillance system (CCDSS) Osteoporosis working group. Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a\u00a0feasibility study. Arch Osteoporos 8:143","DOI":"10.1007\/s11657-013-0143-2"},{"key":"6690_CR12","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM et al (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864\u20131873","journal-title":"CMAJ"},{"key":"6690_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"6690_CR14","doi-asserted-by":"publisher","first-page":"652979","DOI":"10.3389\/fphar.2021.652979","volume":"12","author":"CC Wu","year":"2021","unstructured":"Wu CC, Chen PY, Wang SW et al (2021) Risk of fracture during androgen deprivation therapy among patients with prostate cancer: a systematic review and meta-analysis of cohort studies. Front Pharmacol 12:652979","journal-title":"Front Pharmacol"},{"key":"6690_CR15","doi-asserted-by":"crossref","unstructured":"Lee YK, Lee EG, Kim HY, Lee Y, Lee SM, Suh DC, Yoo JI, Lee S (2020) Osteoporotic fractures of the spine, hip, and other locations after adjuvant endocrine therapy with Aromatase inhibitors in breast cancer patients: a metaanalysis. J Korean Med Sci 35(46):e403","DOI":"10.3346\/jkms.2020.35.e403"},{"key":"6690_CR16","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","volume":"31","author":"R Coleman","year":"2020","unstructured":"Coleman R, Hadji P, Body J-J et al (2020) Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol 31:1650\u20131663","journal-title":"Ann Oncol"},{"key":"6690_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142020 update. Endocr Pract 26:1\u201346","journal-title":"Endocr Pract"},{"key":"6690_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00223-018-00512-x","volume":"104","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R et al (2019) Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Calcif Tissue Int 104:235\u2013238","journal-title":"Calcif Tissue Int"},{"key":"6690_CR19","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.2217\/fon-2019-0666","volume":"16","author":"JJ Luke","year":"2020","unstructured":"Luke JJ, Ascierto PA, Carlino MS et al (2020) KEYNOTE-716: phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncol 16:4429\u20134438","journal-title":"Future Oncol"},{"key":"6690_CR20","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.21037\/tlcr-20-546","volume":"9","author":"A Ortega-Franco","year":"2020","unstructured":"Ortega-Franco A, Calvo V, Franco F et al (2020) Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review. Transl Lung Cancer Res 9:2656\u20132673","journal-title":"Transl Lung Cancer Res"},{"key":"6690_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.critrevonc.2018.10.011","volume":"133","author":"PA van Dam","year":"2019","unstructured":"van Dam PA, Verhoeven Y, Trinh XB et al (2019) RANK\/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment. Crit Rev Oncol Hematol 133:85\u201391","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06690-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06690-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06690-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T04:05:44Z","timestamp":1679976344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06690-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["6690"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06690-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"25 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Health Research Ethics Board of Alberta Cancer Committee. Individual patient consent was not required due to the nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Individual consent for publication was not required due to the nature of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}]}}